Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CM&D Pharma
London, England, United Kingdompmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CM&D Pharma developed Fostrap, a medical chewing gum designed to bind phosphate in the saliva of patients with chronic kidney disease, aiming to reduce serum phosphate levels. Clinical trials were conducted with promising preliminary results, but the program was discontinued post-acquisition[2][4].
- Therapeutic areas
- NephrologyGastroenterologyOncology
- Modalities
- Medical food (Foods for Special Medical Purposes)Device (chewing gum delivery)
- Industry
- Therapeutic Medical Devices
02
Partnerships
University of Messina (originator organization for Fostrap)[4]
Beyond the preview
Go deeper on CM&D Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CM&D Pharma.